AST of mycobacteria

Antimicrobial susceptibility testing of Mycobacteria


So far EUCAST has determined breakpoints for two new anti-tuberculous agents, delamanid and bedaquiline. Breakpoints for these were included in the breakpoint tables, version 5.0 published on the 1st January 2015.

In order to help EUCAST to determine breakpoints for anti-tuberculous agents and to assess methods for MIC determination, EUCAST collaborates with the ESCMID Study Group for Mycobacterial Infections (ESGMYC). At a workshop held in late 2014 and involving EUCAST, ESGMYC and the EMA, the collaboration and proposals for future action were outlined."


Workshop on recommendations for pharmaceutical companies regarding data required for new antituberculous drugs

11-12 November 2014, Basel, Switzerland